Introduction: Atrial fibrillation (AF) is the commonest persistent cardiac arrhythmia with an
estimated incidence rate of between 1.5–2% and an important cause of strokes. Few …

Aims We sought to investigate the association between sex and oral anticoagulation control
employing coumarin derivatives. Methods Electronic sources were MEDLINE, Biblioteca …

Background Worldwide atrial fibrillation (AF) prevalence varies between 0.1% and 4.0%,
and has been increasing. Little is known about the prevalence of AF in Brazil. Our objective …

Objective: To analyze the association between time of arrival at a reference hospital and
mortality of people with ischemic stroke. Method: Descriptive and inferential statistics were …

Background: The safety and effectiveness of warfarin depend on anticoagulation control
quality. Observational studies associate poor control with increased morbidity, mortality and …

Background The prospective, observational XANTUS study demonstrated low rates of stroke
and major bleeding in real-world rivaroxaban-treated patients with non-valvular atrial …

Background ROCKET AF demonstrated the efficacy and safety of rivaroxaban compared
with warfarin for the prevention of stroke and systemic embolism (SE) in patients with atrial …

Background Atrial fibrillation (AF) negatively impacts health systems worldwide. We aimed to
capture perceptions of and barriers and facilitators for AF care in Brazilian primary care units …

Background Warfarin is the only oral anticoagulant available in the Brazilian public health
system. Health knowledge and treatment are essential to achieving the desirable …

Atrial fibrillation (AF) is a prominent risk factor for stroke and a leading cause of death and
disability throughout Latin America. Contemporary evidence-based guidelines for the …